Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot.

[1]  V. Somers,et al.  Heart Rate Variability: , 2003, Journal of cardiovascular electrophysiology.

[2]  J. Sponring,et al.  Regional Wall Motion and Abnormalities of Electrical Depolarization and Repolarization in Patients After Surgical Repair of Tetralogy of Fallot , 2001, Circulation.

[3]  S. Siu,et al.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.

[4]  D. Chemla,et al.  Arrhythmic right ventricular cardiomyopathy 1 113 June 2000 , 2000 .

[5]  R. Peverill Possible mechanisms of increased blood viscosity in systemic hypertension. , 2000, The American journal of cardiology.

[6]  G. Danieli,et al.  Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43. , 2000, The American journal of cardiology.

[7]  L. Daliento,et al.  Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot , 1999, Heart.

[8]  Geoffrey I. Webb,et al.  Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. , 1997, Journal of the American College of Cardiology.

[9]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[10]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[11]  M. Dae,et al.  Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG): Is there a clinical application? , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  G. Breithardt,et al.  Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.

[13]  D. Zipes,et al.  Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. , 1993, Journal of the American College of Cardiology.

[14]  M. Schlepper,et al.  123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. , 1993, European heart journal.

[15]  A. Camm,et al.  Asymmetry of cardiac [1231] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart , 2022 .

[16]  Robert H. Anderson,et al.  The morphologic substrates for pediatric arrhythmias , 1991, Cardiology in the Young.

[17]  K. Nakajima,et al.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. , 1990, American heart journal.

[18]  M. Akers,et al.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.

[19]  D. Zipes,et al.  Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. , 1985, Circulation.

[20]  L. Freeman,et al.  Nuclear medicine annual. , 1982 .